Adjuvant use of epidermal growth factor receptor kinase inhibitors may prevent bone metastases in patients with non-small cell lung carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/18090592

Download in:

View as

General Info

PMID
18090592